Reuters logo
9 天前
BRIEF-Chiasma reached deal with FDA on late-stage trial of its acromegaly drug
2017年8月10日 / 晚上8点10分 / 9 天前

BRIEF-Chiasma reached deal with FDA on late-stage trial of its acromegaly drug

Aug 10 (Reuters) - Chiasma Inc

* Chiasma reaches agreement with FDA under special protocol assessment for a new phase 3 clinical trial of octreotide capsules in acromegaly

* Chiasma reaches agreement with fda under special protocol assessment for a new phase 3 clinical trial of octreotide capsules in acromegaly

* Chiasma Inc - ‍plans to initiate enrollment in new phase 3 clinical trial - optimal - during second half of 2017​

* Chiasma Inc - ‍anticipates release of top-line data from new optimal trial by end of 2019​

* Says "‍based on our current plans, we expect to have a cash and investment balance of at least $60 million at end of 2017"​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below